Pavankumar Kothamasu*, Hemanth Kanumur, Niranjan Ravur, Chiranjeevi Maddu, Radhika Parasuramrajam, Sivakumar Thangavel
|
Marziyeh Fathi, Jaleh Barar* 
|
Marziyeh Fathi, Parham Sahandi Zangabad, Sima Majidi, Jaleh Barar, Hamid Erfan-Niya, Yadollah Omidi*
|
Somayeh Vandghanooni, Morteza Eskandani, Jaleh Barar , Yadollah Omidi*
Aptamers (Aps) are short single-strand nucleic acids, which can be used as the therapeutic and targeting agent in advanced drug delivery systems. Conjugation of Aps with other entities (siRNA, toxins, drugs, DNAzyme/Ribozymes) provides advanced multifunctional nanosystems for cancer therapy.
|
Marziyeh Fathi , Azam Safary , Jaleh Barar*
Jaleh Barar (PharmD, PhD) is Professor of Drug Delivery and Targeting. She currently is the chair of the department of Pharmaceutics at the Faculty of Pharmacy, Tabriz university of Medical Sciences. Professor Barar’s research is focused on various aspects of the pharmaceutical cell biology with the particular emphasis on the development of novel drug delivery and targeting strategies to combat cancer.
|
Tejpal Yadav , Hemant Kumar Singh Yadav , Abhay Raizaday , Md Sabir Alam*
|